TNBC history map

344 active and 333 discontinued TNBC programs, from first public evidence to today, by modality and stage.

Timeline View

Discontinued programs run from first public evidence to last public news, active programs from first public evidence to today. Stage = furthest stage reached (discontinued) or current stage (active). Click a name for details, a reason or marker for its source.

Legend for discontinued programs
Reason: Efficacy Safety Strategic Not disclosed
Line: activity, then later news after discontinuation
Markers: milestone discontinuation announced corporate event corporate event after the last TNBC news
Active programs: first public evidence, then active to today
Show:
  1. Phase 2
  2. Phase 2
  3. Phase 2
  4. Phase 3+
  5. Phase 2
  6. Phase 3+
    (Active)
  7. Phase 3+
    (Active)
  8. Phase 2
  9. Phase 3+
    (Active)
  10. Phase 3+
  11. Phase 2
  12. Phase 3+
    (Active)
  13. Phase 2
  14. Phase 1
  15. Phase 1
  16. Phase 2
  17. Preclinical
  18. Phase 2
  19. Phase 1
  20. Phase 2
  21. Phase 2
    (Active)
  22. Phase 2
  23. Phase 2
    (Active)
  24. Phase 1
  25. IND
  26. Preclinical
  27. Phase 2
  28. Phase 2
  29. Phase 2
  30. Phase 2
    (Active)
  31. Phase 2
    (Active)
  32. Phase 2
    (Active)
  33. Phase 2
  34. Phase 2
  35. Phase 2
  36. Phase 2
  37. Phase 2
  38. Phase 2
    (Active)
  39. Phase 2
  40. Phase 2
  41. Phase 2
    (Active)
  42. Phase 2
  43. Phase 2
  44. Phase 2
  45. Phase 2
  46. Phase 3+
    (Active)
  47. Phase 2
  48. Phase 2
    (Active)
  49. Phase 2
  50. Phase 2
    (Active)
  51. Phase 2
    (Active)
  52. Phase 2
  53. Phase 2
  54. Phase 1
  55. Phase 1
  56. Phase 2
    (Active)
  57. Phase 1
  58. Phase 2
    (Active)
  59. Phase 2
  60. Phase 1
    (Active)
  61. Preclinical
  62. Phase 2
  63. Phase 3+
    (Active)
  64. Phase 2
  65. Phase 1
  66. Phase 2
  67. Phase 2
  68. Phase 2
  69. Phase 2
  70. Phase 1
  71. Phase 3+
  72. Approved
    (Active)
  73. Phase 2
  74. Phase 2
  75. Phase 3+
    (Active)
  76. Phase 1
  77. Phase 1
  78. Phase 2
  79. Phase 2
  80. Phase 2
    (Active)
  81. Phase 2
  82. Preclinical
  83. Phase 1
  84. Phase 2
  85. Phase 1
  86. Phase 1
  87. Preclinical
  88. Phase 2
  89. Phase 2
  90. Phase 1
  91. Phase 2
    (Active)
  92. Phase 3+
    (Active)
  93. Approved
    (Active)
  94. Phase 2
  95. Phase 2
    (Active)
  96. Phase 1
  97. Preclinical
  98. Preclinical
  99. Phase 1
  100. Phase 2
    (Active)
  101. Phase 2
  102. Phase 2
  103. Phase 2
  104. Phase 2
    (Active)
  105. Phase 1
  106. Phase 2
  107. Phase 2
  108. Phase 2
  109. Phase 2
    (Active)
  110. Phase 2
  111. Preclinical
  112. Preclinical
  113. Preclinical
  114. Preclinical
  115. Phase 2
    (Active)
  116. Phase 2
  117. Phase 2
    (Active)
  118. Phase 2
  119. Phase 2
  120. Phase 1
  121. Phase 3+
  122. Phase 2
    (Active)
  123. Phase 1
    (Active)
  124. Phase 2
  125. Phase 2
  126. Phase 2
  127. Phase 2
  128. Phase 3+
    (Active)
  129. Phase 3+
    (Active)
  130. Phase 1
  131. Phase 1
  132. Phase 2
    (Active)
  133. Phase 1
  134. Phase 2
    (Active)
  135. Phase 1
  136. Phase 3+
    (Active)
  137. Phase 1
    (Active)
  138. Phase 1
  139. Phase 2
  140. Phase 1
  141. Phase 1
  142. Phase 2
  143. Phase 2
  144. Phase 1
  145. Phase 2
    (Active)
  146. Phase 2
    (Active)
  147. Phase 2
  148. Preclinical
  149. Phase 2
    (Active)
  150. Phase 1
    (Active)
  151. Phase 2
  152. Phase 1
  153. Phase 2
  154. Phase 2
  155. Phase 1
  156. Phase 1
  157. Phase 2
  158. Phase 2
    (Active)
  159. Phase 2
  160. Phase 2
  161. Preclinical
  162. Phase 2
    (Active)
  163. Phase 2
  164. Phase 2
    (Active)
  165. Phase 2
    (Active)
  166. Phase 1
  167. Phase 2
  168. Phase 3+
    (Active)
  169. Phase 2
  170. Phase 2
    (Active)
  171. Phase 2
  172. Phase 2
  173. Phase 2
  174. Preclinical
  175. Preclinical
  176. Phase 3+
    (Active)
  177. Phase 1
  178. Phase 2
  179. IND
  180. Phase 1
  181. Phase 2
  182. Phase 2
  183. Phase 2
  184. Phase 2
  185. Preclinical
  186. Phase 2
  187. Phase 2
  188. Phase 1
  189. Phase 1
    (Active)
  190. Phase 1
    (Active)
  191. Phase 2
    (Active)
  192. Phase 2
  193. Phase 1
  194. Phase 2
    (Active)
  195. Phase 3+
    (Active)
  196. Preclinical
  197. Preclinical
  198. Phase 1
  199. Phase 1
  200. Phase 1
  201. Phase 1
  202. Phase 1
  203. Phase 1
    (Active)
  204. Phase 1
  205. Phase 2
  206. Phase 1
  207. Phase 1
  208. Phase 3+
  209. Phase 2
  210. Phase 2
  211. Phase 2
  212. Phase 2
  213. Phase 2
  214. Phase 1
    (Active)
  215. Phase 2
  216. Preclinical
  217. Preclinical
  218. Preclinical
  219. Phase 1
  220. Phase 1
    (Active)
  221. Phase 3+
    (Active)
  222. Phase 2
  223. Phase 2
  224. Phase 1
  225. Preclinical
  226. Phase 1
  227. Phase 2
    (Active)
  228. Phase 2
  229. Phase 2
  230. Phase 2
  231. Phase 2
  232. Phase 2
  233. Phase 2
  234. Phase 2
  235. Phase 1
  236. Phase 2
  237. Phase 1
  238. Phase 2
  239. Preclinical
  240. Preclinical
  241. Phase 1
  242. Phase 1
  243. Phase 1
  244. Preclinical
  245. Phase 1
  246. Phase 2
  247. Phase 1
  248. Preclinical
  249. Phase 1
  250. Phase 1
  251. Phase 2
  252. Phase 1
  253. Phase 2
  254. Phase 2
  255. Phase 2
  256. Phase 2
    (Active)
  257. Phase 2
  258. Preclinical
    (Active)
  259. Preclinical
    (Active)
  260. Preclinical
  261. Phase 1
  262. Phase 3+
    (Active)
  263. Phase 2
  264. Approved
    (Active)
  265. Phase 2
  266. Phase 2
    (Active)
  267. Phase 1
  268. Phase 1
  269. Phase 2
  270. Phase 1
  271. Phase 2
  272. Phase 3+
    (Active)
  273. Phase 2
    (Active)
  274. Phase 1
  275. Phase 2
  276. Phase 2
  277. Phase 2
  278. Phase 2
    (Active)
  279. Phase 2
  280. Phase 2
  281. Preclinical
  282. Phase 2
    (Active)
  283. Phase 2
    (Active)
  284. Phase 1
  285. Preclinical
  286. Phase 2
    (Active)
  287. Phase 2
  288. Phase 2
  289. Preclinical
  290. Phase 1
  291. Phase 3+
    (Active)
  292. Phase 3+
  293. Phase 1
  294. Preclinical
  295. Phase 1
  296. Phase 2
    (Active)
  297. Phase 2
  298. Phase 2
    (Active)
  299. Phase 1
  300. Phase 2
  301. Phase 2
  302. Phase 1
  303. Approved
    (Active)
  304. Phase 1
  305. Phase 1
  306. Phase 2
  307. Phase 2
  308. Phase 1
  309. Preclinical
  310. Preclinical
  311. Preclinical
    (Active)
  312. Phase 1
    (Active)
  313. Phase 2
  314. Phase 2
    (Active)
  315. Phase 2
  316. Phase 1
  317. Phase 2
    (Active)
  318. Phase 3+
    (Active)
  319. Phase 3+
    (Active)
  320. Phase 1
  321. Phase 2
  322. Phase 1
  323. Phase 1
    (Active)
  324. Phase 2
    (Active)
  325. Phase 2
    (Active)
  326. Phase 1
  327. Phase 2
  328. Preclinical
  329. Phase 2
  330. Phase 1
    (Active)
  331. Phase 1
  332. Phase 2
  333. Phase 2
  334. Phase 2
  335. Preclinical
    (Active)
  336. Preclinical
  337. Phase 2
    (Active)
  338. Phase 1
    (Active)
  339. Phase 1
  340. Phase 2
    (Active)
  341. Phase 3+
    (Active)
  342. Phase 1
    (Active)
  343. Phase 1
  344. Phase 2
    (Active)
  345. Phase 1
  346. Phase 2
  347. Approved
    (Active)
  348. Phase 1
  349. Phase 2
    (Active)
  350. Preclinical
    (Active)
  351. Phase 2
    (Active)
  352. Preclinical
    (Active)
  353. Preclinical
    (Active)
  354. Preclinical
    (Active)
  355. Preclinical
    (Active)
  356. Phase 2
    (Active)
  357. Phase 1
  358. Phase 2
    (Active)
  359. IND
  360. Phase 2
    (Active)
  361. Phase 1
    (Active)
  362. Phase 1
  363. Phase 1
  364. Phase 2
    (Active)
  365. Phase 3+
    (Active)
  366. Phase 3+
    (Active)
  367. Phase 1
  368. Phase 1
  369. Phase 2
    (Active)
  370. Phase 2
    (Active)
  371. Phase 2
    (Active)
  372. Phase 2
  373. Phase 1
    (Active)
  374. Phase 2
    (Active)
  375. Phase 2
  376. Phase 2
  377. Phase 1
    (Active)
  378. Phase 3+
    (Active)
  379. Phase 1
  380. Phase 2
  381. Phase 1
  382. Preclinical
    (Active)
  383. Phase 1
  384. Preclinical
  385. Phase 2
    (Active)
  386. Phase 2
    (Active)
  387. Phase 2
  388. Phase 2
  389. Phase 2
  390. Phase 1
  391. Preclinical
  392. Phase 2
  393. Phase 2
  394. Phase 1
    (Active)
  395. Phase 2
  396. Phase 2
  397. Phase 1
    (Active)
  398. Phase 2
    (Active)
  399. Preclinical
  400. Preclinical
    (Active)
  401. Phase 2
    (Active)
  402. Phase 1
    (Active)
  403. Phase 2
  404. Phase 3+
    (Active)
  405. Phase 2
    (Active)
  406. Phase 2
  407. Phase 1
  408. Phase 2
  409. Phase 2
    (Active)
  410. Phase 2
    (Active)
  411. Phase 1
  412. Phase 3+
    (Active)
  413. Phase 1
  414. Phase 1
  415. Preclinical
  416. Phase 2
    (Active)
  417. Phase 2
  418. Phase 2
    (Active)
  419. Phase 1
    (Active)
  420. Preclinical
    (Active)
  421. Phase 2
    (Active)
  422. Phase 2
  423. Phase 2
    (Active)
  424. Phase 2
    (Active)
  425. Phase 2
    (Active)
  426. Phase 2
    (Active)
  427. Phase 2
    (Active)
  428. Phase 3+
    (Active)
  429. Phase 1
    (Active)
  430. Phase 2
    (Active)
  431. Phase 1
    (Active)
  432. Phase 1
    (Active)
  433. Phase 1
  434. Phase 1
  435. Phase 2
  436. Phase 2
  437. Phase 1
    (Active)
  438. Phase 2
  439. Phase 2
    (Active)
  440. Phase 1
    (Active)
  441. Phase 2
    (Active)
  442. Preclinical
    (Active)
  443. Preclinical
    (Active)
  444. Preclinical
    (Active)
  445. Preclinical
    (Active)
  446. Preclinical
    (Active)
  447. Preclinical
    (Active)
  448. Phase 3+
    (Active)
  449. Phase 1
  450. Phase 2
  451. Phase 2
  452. Phase 2
    (Active)
  453. Phase 3+
    (Active)
  454. Phase 1
    (Active)
  455. Phase 2
    (Active)
  456. Phase 1
  457. Phase 2
    (Active)
  458. Phase 2
    (Active)
  459. Phase 2
    (Active)
  460. Phase 2
  461. Phase 3+
    (Active)
  462. Phase 2
    (Active)
  463. Phase 2
  464. Phase 2
    (Active)
  465. Phase 2
  466. Phase 1
    (Active)
  467. Phase 1
    (Active)
  468. Phase 1
    (Active)
  469. Phase 1
  470. Phase 2
    (Active)
  471. Phase 2
    (Active)
  472. Phase 2
  473. Phase 1
  474. Phase 1
  475. Preclinical
    (Active)
  476. Phase 1
    (Active)
  477. Phase 2
    (Active)
  478. Phase 2
    (Active)
  479. Phase 2
    (Active)
  480. Phase 2
    (Active)
  481. Preclinical
    (Active)
  482. Phase 2
    (Active)
  483. Phase 2
    (Active)
  484. Phase 2
    (Active)
  485. Phase 1
    (Active)
  486. Phase 2
    (Active)
  487. Phase 1
    (Active)
  488. Phase 1
    (Active)
  489. Phase 1
  490. Phase 2
    (Active)
  491. Phase 3+
  492. Preclinical
    (Active)
  493. Phase 2
    (Active)
  494. Phase 1
  495. Phase 2
    (Active)
  496. Phase 2
    (Active)
  497. Phase 2
    (Active)
  498. Phase 2
    (Active)
  499. Phase 3+
    (Active)
  500. Phase 2
    (Active)
  501. Phase 2
    (Active)
  502. Phase 2
    (Active)
  503. Phase 1
  504. Preclinical
    (Active)
  505. Phase 1
    (Active)
  506. Phase 2
    (Active)
  507. Preclinical
    (Active)
  508. Preclinical
    (Active)
  509. Preclinical
    (Active)
  510. Preclinical
    (Active)
  511. Preclinical
    (Active)
  512. Phase 2
    (Active)
  513. Phase 2
    (Active)
  514. Phase 1
  515. Phase 2
    (Active)
  516. Phase 1
    (Active)
  517. Phase 2
    (Active)
  518. Phase 2
    (Active)
  519. Phase 2
  520. Preclinical
    (Active)
  521. Preclinical
    (Active)
  522. Phase 1
    (Active)
  523. Phase 2
  524. Phase 2
    (Active)
  525. Phase 2
    (Active)
  526. Phase 1
  527. Phase 2
  528. Preclinical
    (Active)
  529. Phase 2
    (Active)
  530. Phase 2
  531. Preclinical
    (Active)
  532. Phase 2
    (Active)
  533. Phase 2
    (Active)
  534. Phase 2
    (Active)
  535. Preclinical
    (Active)
  536. Phase 1
  537. Phase 2
  538. Phase 2
    (Active)
  539. Phase 1
  540. Phase 3+
    (Active)
  541. Phase 3+
    (Active)
  542. Phase 1
    (Active)
  543. Phase 2
    (Active)
  544. Phase 1
    (Active)
  545. Phase 1
  546. Phase 2
  547. Phase 2
    (Active)
  548. Phase 2
  549. Phase 2
    (Active)
  550. Phase 1
    (Active)
  551. Phase 2
  552. Phase 2
    (Active)
  553. Phase 2
  554. Phase 1
    (Active)
  555. Phase 2
  556. Preclinical
    (Active)
  557. Phase 1
    (Active)
  558. Preclinical
    (Active)
  559. IND
    (Active)
  560. Phase 2
    (Active)
  561. Phase 2
    (Active)
  562. Phase 1
    (Active)
  563. Phase 1
    (Active)
  564. Phase 2
  565. Phase 1
  566. Phase 2
    (Active)
  567. Phase 1
  568. Phase 1
    (Active)
  569. Phase 1
    (Active)
  570. Phase 3+
    (Active)
  571. Phase 1
  572. Phase 1
    (Active)
  573. Phase 1
    (Active)
  574. Phase 2
    (Active)
  575. Phase 2
    (Active)
  576. Phase 2
    (Active)
  577. Phase 2
    (Active)
  578. Phase 2
    (Active)
  579. Phase 1
    (Active)
  580. Phase 2
    (Active)
  581. Phase 2
    (Active)
  582. Phase 1
    (Active)
  583. Phase 1
    (Active)
  584. Phase 2
    (Active)
  585. Phase 2
    (Active)
  586. Phase 2
    (Active)
  587. Phase 1
    (Active)
  588. Phase 1
    (Active)
  589. Phase 1
    (Active)
  590. Phase 2
  591. Phase 1
    (Active)
  592. Preclinical
    (Active)
  593. Phase 2
    (Active)
  594. Phase 2
    (Active)
  595. Phase 2
    (Active)
  596. Phase 2
    (Active)
  597. Phase 1
    (Active)
  598. Phase 2
    (Active)
  599. Phase 2
    (Active)
  600. Phase 2
    (Active)
  601. Phase 2
    (Active)
  602. Phase 3+
    (Active)
  603. Phase 1
    (Active)
  604. Phase 2
  605. Phase 2
    (Active)
  606. Phase 3+
    (Active)
  607. Phase 2
    (Active)
  608. Preclinical
    (Active)
  609. Phase 1
    (Active)
  610. Preclinical
    (Active)
  611. Phase 2
    (Active)
  612. Phase 1
    (Active)
  613. Phase 2
    (Active)
  614. Phase 1
    (Active)
  615. Phase 3+
    (Active)
  616. Preclinical
    (Active)
  617. Phase 2
    (Active)
  618. Phase 2
    (Active)
  619. Phase 1
  620. Phase 2
    (Active)
  621. Phase 2
    (Active)
  622. Phase 2
    (Active)
  623. Phase 2
    (Active)
  624. Phase 2
    (Active)
  625. Phase 2
    (Active)
  626. Phase 2
  627. Phase 1
    (Active)
  628. Phase 1
  629. Phase 2
    (Active)
  630. Preclinical
    (Active)
  631. Preclinical
    (Active)
  632. Preclinical
    (Active)
  633. Phase 1
    (Active)
  634. Phase 2
    (Active)
  635. Phase 1
    (Active)
  636. Phase 1
    (Active)
  637. Phase 2
    (Active)
  638. Phase 2
    (Active)
  639. Phase 1
    (Active)
  640. Phase 1
    (Active)
  641. Preclinical
    (Active)
  642. Preclinical
    (Active)
  643. Preclinical
    (Active)
  644. Preclinical
    (Active)
  645. Preclinical
    (Active)
  646. Phase 2
    (Active)
  647. Phase 1
    (Active)
  648. Phase 2
    (Active)
  649. Preclinical
    (Active)
  650. Phase 1
  651. Phase 2
    (Active)
  652. Phase 2
    (Active)
  653. Phase 2
    (Active)
  654. Phase 2
    (Active)
  655. Phase 1
    (Active)
  656. Phase 2
    (Active)
  657. Phase 1
    (Active)
  658. Phase 3+
    (Active)
  659. Phase 2
    (Active)
  660. Phase 2
    (Active)
  661. Phase 1
    (Active)
  662. Phase 1
    (Active)
  663. Phase 1
    (Active)
  664. Phase 2
    (Active)
  665. Phase 3+
    (Active)
  666. Phase 2
    (Active)
  667. Preclinical
    (Active)
  668. Phase 2
    (Active)
  669. Phase 2
    (Active)
  670. Phase 2
    (Active)
  671. Phase 2
    (Active)
  672. Phase 1
    (Active)
  673. Phase 1
    (Active)
  674. Preclinical
    (Active)
  675. Phase 2
    (Active)
  676. Phase 3+
    (Active)
  677. Phase 2
    (Active)

Pipeline View

Small moleculeOligonucleotideGene / cell therapyAntibody / biologicUndisclosedRepurposing
Active Possibly inactive Discontinued Click a program for details
Show:
Active and discontinued TNBC programs by modality and stage
ModalityPreclinicalINDPhase 1Phase 2Phase 3+Approved
Targeted payload delivery
Checkpoint and T-cell activation
Innate immunity and tumor microenvironment
Cell therapies and vaccines
DNA damage response
Epigenetic and transcriptional
Growth signaling and cell cycle
Cell death and metabolism
Cytotoxic and anti-angiogenic
Undisclosed
Repurposing